ResMed Inc (RMD)

Net profit margin

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 1,400,723 1,313,254 1,248,705 1,112,883 1,020,950 958,378 890,386 906,500 897,556 862,953 809,465 786,302 779,437 779,474 521,981 499,744 474,503 457,240 698,858 679,898
Revenue (ttm) US$ in thousands 5,146,330 5,021,540 4,926,780 4,807,490 4,546,017 4,444,877 4,364,797 4,235,737 4,222,994 4,015,671 3,763,271 3,624,405 3,578,126 3,539,492 3,443,759 3,348,896 3,196,825 3,091,065 3,091,753 3,027,899
Net profit margin 27.22% 26.15% 25.35% 23.15% 22.46% 21.56% 20.40% 21.40% 21.25% 21.49% 21.51% 21.69% 21.78% 22.02% 15.16% 14.92% 14.84% 14.79% 22.60% 22.45%

June 30, 2025 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,400,723K ÷ $5,146,330K
= 27.22%

The net profit margin of ResMed Inc. demonstrates notable fluctuations over the analyzed period. From September 30, 2020, to December 31, 2021, the margin remained relatively stable, oscillating around the 14.8% to 15.2% range. This indicates a period of consistent profitability margins amidst steady revenues and expenses during this timeframe.

In the subsequent period from March 31, 2022, to September 30, 2022, the net profit margin experienced minimal slight decline, settling approximately between 21.69% and 21.78%. This suggests an improvement in profitability, potentially attributable to increased revenues, cost efficiencies, or both.

However, the end of 2022 marked a slight decrease, with the margin dropping to approximately 20.40% by December 31, 2023. Despite this, the margin remained within a relatively consistent band from March 2023 through the first half of 2024, fluctuating narrowly around 21.25% to 21.56%.

From the second half of 2024 onward, a significant upward trend emerges. The net profit margin climbs substantially, reaching 25.35% as of December 31, 2024, and further increasing in the subsequent quarters to 26.15% by March 31, 2025, and 27.22% by June 30, 2025. This sharp increase indicates improved profitability efficiencies, possibly driven by higher revenue quality, cost containment strategies, or favorable market conditions.

In summary, while the company experienced relatively stable profit margins in the earlier years, recent periods reflect an improving trend, culminating in a substantial increase in net profit margin by mid-2025. This progression suggests enhanced profitability and operational efficiency over the analyzed timeframe.